⌘K

Home/Filings/4/0001209191-21-041571

4//SEC Filing

Afable Richard 4

Accession 0001209191-21-041571

CIK 0001427925other

View on SEC.gov Company Profile

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 5:28 PM ET

Size

7.4 KB

Accession

0001209191-21-041571

Insider Transaction Report

Form 4

Period: 2021-06-17

ACELRX PHARMACEUTICALS INCACRX

Director

Transactions

Award
Stock Option (Right to Buy)
2021-06-17+20,000→ 20,000 total
Exercise: $1.41From: 2022-06-17Exp: 2031-06-16→ Common Stock (20,000 underlying)
Award
Common Stock
2021-06-17+10,000→ 22,250 total

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F2]100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
[F3]100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ACELRX PHARMACEUTICALS INC

CIK 0001427925

Entity typeother

Related Parties

1

filerCIK 0001594021

Filing Metadata

Form type: 4
Filed: Jun 16, 8:00 PM ET
Accepted: Jun 17, 5:28 PM ET
Size: 7.4 KB

View on SEC.gov